Product image of Linezolid Hikma (Linezolid) supplied by GNH India

Linezolid Hikma

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Hikma (Linezolid)

Linezolid, the active ingredient in Linezolid Hikma, is an oxazolidinone antibiotic presented as an intravenous solution for injection use. It treats serious bacterial infections, including complicated skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, and infections caused by MRSA or VRE, in adult patients.

GNH India supplies Linezolid Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution. Customers benefit from reliable supply chains and responsive technical support.

Manufacturer / TM Owner

Hikma Farmacêutica (Portugal), S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria.

  • Complicated skin and soft tissue infections: effective therapy for adult patients with infections caused by susceptible Gram‑positive organisms.
  • Community‑acquired bacterial pneumonia: provides bacterial clearance in patients with pneumonia due to susceptible pathogens.
  • Nosocomial pneumonia: used for hospital‑acquired lung infections when other agents are unsuitable.
  • MRSA and VRE infections: offers an option for resistant Gram‑positive infections where alternatives may be limited.

How It Works

  • Linezolid binds to the 50S ribosomal subunit of susceptible bacteria, preventing the formation of the initiation complex required for protein synthesis. By inhibiting the early stage of translation, it halts bacterial growth and leads to bacteriostatic activity against most Gram‑positive organisms, including resistant strains such as MRSA and VRE.

Side Effects

Linezolid may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools that may be self‑limiting.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste perception.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count requiring monitoring.
  • Anemia: reduced red blood cell levels.
  • Peripheral neuropathy: nerve damage presenting as tingling or numbness.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Lactic acidosis: rare metabolic disturbance.
  • Severe hepatic injury: potential liver enzyme elevation.

Precautions & Warnings

Before initiating therapy, clinicians should assess patient‑specific factors and monitor for potential complications.

  • Renal impairment: adjust therapy based on renal function and monitor for accumulation.
  • Hepatic impairment: monitor liver enzymes regularly during treatment.
  • Concomitant serotonergic agents: avoid due to risk of serotonin syndrome.
  • Myelosuppression: perform complete blood‑count monitoring to detect thrombocytopenia or anemia.
  • Hypersensitivity: discontinue immediately if allergic reaction occurs.
  • Store at ambient temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Linezolid can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): may precipitate serotonin syndrome.
  • Rifampin: reduces linezolid plasma concentrations, compromising efficacy.
  • Tyramine‑rich foods: may elevate blood pressure when combined.
  • Serotonergic opioids (e.g., tramadol): heightened serotonin syndrome risk.

Moderate Interactions (Monitor Closely)

  • Warfarin: may increase INR; monitor coagulation parameters.
  • Cytochrome P450 inducers (e.g., carbamazepine): may lower linezolid exposure, requiring efficacy assessment.

Frequently Asked Questions

Linezolid Hikma is indicated for the treatment of serious Gram‑positive bacterial infections, including complicated skin and soft‑tissue infections, community‑acquired and nosocomial pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) or vancomycin‑resistant Enterococcus (VRE). It is administered to adult patients when these pathogens are identified or strongly suspected.

Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. This prevents the formation of the initiation complex required for translation, resulting in a bacteriostatic effect against most Gram‑positive organisms, including strains resistant to other antibiotic classes.

The dosing regimen for Linezolid Hikma is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local guidelines. No fixed dose is provided here; prescribers should follow approved labeling and clinical judgment.

Safety data for linezolid during pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant. Clinicians should discuss uncertainties with the patient and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Linezolid offers oral and intravenous options and is active against many resistant Gram‑positive organisms, whereas vancomycin, a glycopeptide, is limited to intravenous use and may have nephrotoxicity concerns. Linezolid’s unique mechanism can be advantageous in MRSA or VRE infections, but it requires monitoring for hematologic toxicity and serotonin‑related interactions.

Store Linezolid Hikma at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from direct light, moisture and extreme temperature fluctuations. Follow standard aseptic techniques when preparing the intravenous solution for infusion.

Linezolid Hikma is supplied for intravenous infusion. The solution is typically diluted in compatible IV fluids and administered over a period defined by the prescriber, often 30–60 minutes. Administration should follow aseptic preparation standards and be monitored for infusion‑related reactions.

Serious adverse events include thrombocytopenia, anemia, peripheral neuropathy, serotonin syndrome (especially with serotonergic drugs), and rare cases of lactic acidosis or severe hepatic injury. Patients should be monitored regularly for blood‑count changes, neurological symptoms, and signs of serotonin excess.

Linezolid Hikma is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation. It should also be avoided in individuals receiving monoamine oxidase inhibitors (MAOIs) or those with uncontrolled hypertension who consume high‑tyramine foods, due to the risk of hypertensive crises.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.